Cargando…
Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study
Hepatic myelopathy is a complication seen in patients with chronic liver failure with physiologic or iatrogenic portosystemic shunting. The main symptom is progressive lower limb dyskinesia. The role of the brain motor control center in hepatic myelopathy is unknown. This study aimed to investigate...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375042/ https://www.ncbi.nlm.nih.gov/pubmed/30688271 http://dx.doi.org/10.4103/1673-5374.249233 |
_version_ | 1783395297702969344 |
---|---|
author | Liu, Kang Chen, Gang Ren, Shu-Yao Zhu, Yuan-Qiang Yu, Tian-Lei Tian, Ping Li, Chen Xi, Yi-Bin Wang, Zheng-Yu Ye, Jian-Jun Han, Guo-Hong Yin, Hong |
author_facet | Liu, Kang Chen, Gang Ren, Shu-Yao Zhu, Yuan-Qiang Yu, Tian-Lei Tian, Ping Li, Chen Xi, Yi-Bin Wang, Zheng-Yu Ye, Jian-Jun Han, Guo-Hong Yin, Hong |
author_sort | Liu, Kang |
collection | PubMed |
description | Hepatic myelopathy is a complication seen in patients with chronic liver failure with physiologic or iatrogenic portosystemic shunting. The main symptom is progressive lower limb dyskinesia. The role of the brain motor control center in hepatic myelopathy is unknown. This study aimed to investigate the gray matter changes in patients with hepatic myelopathy secondary to transjugular intrahepatic portosystemic shunt and to examine their clinical relevance. This was a cross-sectional study. Twenty-three liver failure patients with hepatic myelopathy (hepatic myelopathy group), 23 liver failure patients without hepatic myelopathy (non-hepatic myelopathy group) after transjugular intrahepatic portosystemic shunt, and 23 demographically matched healthy volunteers were enrolled from March 2014 to November 2016 at Xijing Hospital, Air Force Military Medical University (Fourth Military Medical University), China. High-resolution magnetization-prepared rapid gradient-echo brain imaging was acquired. Group differences in regional gray matter were assessed using voxel-based morphometry analysis. The relationship between aberrant gray matter and motor characteristics was investigated. Results demonstrated that compared with the non-hepatic myelopathy group, gray matter volume abnormalities were asymmetric, with decreased volume in the left insula (P = 0.003), left thalamus (P = 0.029), left superior frontal gyrus (P = 0.006), and right middle cingulate cortex (P = 0.021), and increased volume in the right caudate nucleus (P = 0.017), corrected with open-source software. The volume of the right caudate nucleus in the hepatic myelopathy group negatively correlated with the lower limb clinical rating of the Fugl-Meyer Assessment (r = –0.53, P = 0.01). Compared with healthy controls, patients with and without hepatic myelopathy exhibited overall increased gray matter volume in both thalami, and decreased gray matter volume in both putamen, as well as in the globus pallidus, cerebellum, and vermis. The gray matter abnormalities we found predominantly involved motor-related regions, and may be associated with motor dysfunction. An enlarged right caudate nucleus might help to predict weak lower limb motor performance in patients with preclinical hepatic myelopathy after transjugular intrahepatic portosystemic shunt. This study was approved by the Ethics Committee of Xijing Hospital, Air Force Military Medical University (Fourth Military Medical University), China (approval No. 20140227-6) on February 27, 2014. |
format | Online Article Text |
id | pubmed-6375042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-63750422019-05-01 Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study Liu, Kang Chen, Gang Ren, Shu-Yao Zhu, Yuan-Qiang Yu, Tian-Lei Tian, Ping Li, Chen Xi, Yi-Bin Wang, Zheng-Yu Ye, Jian-Jun Han, Guo-Hong Yin, Hong Neural Regen Res Research Article Hepatic myelopathy is a complication seen in patients with chronic liver failure with physiologic or iatrogenic portosystemic shunting. The main symptom is progressive lower limb dyskinesia. The role of the brain motor control center in hepatic myelopathy is unknown. This study aimed to investigate the gray matter changes in patients with hepatic myelopathy secondary to transjugular intrahepatic portosystemic shunt and to examine their clinical relevance. This was a cross-sectional study. Twenty-three liver failure patients with hepatic myelopathy (hepatic myelopathy group), 23 liver failure patients without hepatic myelopathy (non-hepatic myelopathy group) after transjugular intrahepatic portosystemic shunt, and 23 demographically matched healthy volunteers were enrolled from March 2014 to November 2016 at Xijing Hospital, Air Force Military Medical University (Fourth Military Medical University), China. High-resolution magnetization-prepared rapid gradient-echo brain imaging was acquired. Group differences in regional gray matter were assessed using voxel-based morphometry analysis. The relationship between aberrant gray matter and motor characteristics was investigated. Results demonstrated that compared with the non-hepatic myelopathy group, gray matter volume abnormalities were asymmetric, with decreased volume in the left insula (P = 0.003), left thalamus (P = 0.029), left superior frontal gyrus (P = 0.006), and right middle cingulate cortex (P = 0.021), and increased volume in the right caudate nucleus (P = 0.017), corrected with open-source software. The volume of the right caudate nucleus in the hepatic myelopathy group negatively correlated with the lower limb clinical rating of the Fugl-Meyer Assessment (r = –0.53, P = 0.01). Compared with healthy controls, patients with and without hepatic myelopathy exhibited overall increased gray matter volume in both thalami, and decreased gray matter volume in both putamen, as well as in the globus pallidus, cerebellum, and vermis. The gray matter abnormalities we found predominantly involved motor-related regions, and may be associated with motor dysfunction. An enlarged right caudate nucleus might help to predict weak lower limb motor performance in patients with preclinical hepatic myelopathy after transjugular intrahepatic portosystemic shunt. This study was approved by the Ethics Committee of Xijing Hospital, Air Force Military Medical University (Fourth Military Medical University), China (approval No. 20140227-6) on February 27, 2014. Medknow Publications & Media Pvt Ltd 2019-05 /pmc/articles/PMC6375042/ /pubmed/30688271 http://dx.doi.org/10.4103/1673-5374.249233 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Research Article Liu, Kang Chen, Gang Ren, Shu-Yao Zhu, Yuan-Qiang Yu, Tian-Lei Tian, Ping Li, Chen Xi, Yi-Bin Wang, Zheng-Yu Ye, Jian-Jun Han, Guo-Hong Yin, Hong Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study |
title | Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study |
title_full | Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study |
title_fullStr | Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study |
title_full_unstemmed | Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study |
title_short | Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study |
title_sort | regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375042/ https://www.ncbi.nlm.nih.gov/pubmed/30688271 http://dx.doi.org/10.4103/1673-5374.249233 |
work_keys_str_mv | AT liukang regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT chengang regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT renshuyao regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT zhuyuanqiang regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT yutianlei regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT tianping regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT lichen regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT xiyibin regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT wangzhengyu regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT yejianjun regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT hanguohong regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy AT yinhong regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy |